NCT00353665View on ClinicalTrials.gov

Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

January 31, 2009

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

Memantine (Ebixa)

10 mg bid

DRUG

riluzole

riluzole 50 mg bid

DRUG

Placebo

Trial Locations (1)

1649-028

Department of Neurology - Hospital de Santa Maria, Lisbon

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

University of Lisbon

OTHER

NCT00353665 - Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS) | Biotech Hunter | Biotech Hunter